eHealth director Francis Soistman Jr sells $28,174 in common stock

eHealth director Francis S. Soistman Jr. divested a portion of his holdings in the company, selling 40,612 shares of common stock in early October 2026. The transactions, which were executed according to a pre-approved Rule 10b5-1 plan, were carried out at weighted average prices between $0.6913 and $0.6962 per share, resulting in a total sale amount of $28,174.

On October 1, Soistman Jr. sold 20,306 shares at a weighted average price of $0.6962, followed by an additional 20,306 shares the next day at a weighted average price of $0.6913. Individual transaction prices for these latter shares ranged between $0.6801 and $0.7023. Following these sales, Soistman Jr. retained ownership of 974,609 shares of eHealth common stock.

Interestingly, the insider sale occurred as the company's shares were trading at $0.67, marking an 85% decline year-to-date and representing the stock's 52-week low. Despite this downward trend, investment analysis suggests that eHealth is undervalued, with a Fair Value of $0.97, placing the stock among the platform's most undervalued equities.

eHealth reported its second-quarter 2026 earnings on October 2, 2026, with total revenue of $33.6 million, in line with analysts' expectations of $33.62 million. However, the company posted a wider net loss and a larger adjusted EBITDA loss compared to the same period in the previous year. The company's operating cash flow showed significant improvement.

In response to the earnings report, investment firm RBC Capital lowered its price target for eHealth from $3.00 to $2.00, maintaining a Sector Perform rating. The firm revised its financial model following the earnings release, noting that revenue fell short of its own estimate of $34.7 million. eHealth is currently undergoing a strategic transition toward a lifetime advisory model.